healthcare
healthcare Articles
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid...
Published:
Last Updated:
GTx shares were absolutely crushed on Friday after the company announced results from its mid-stage trial in post-menopausal women with stress urinary incontinence.
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Published:
Last Updated:
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
Published:
Last Updated:
AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit from the California Department of Insurance in regards to allegedy kickbacks given to...
Published:
Last Updated:
Clovis shares might not be showing it now, but the company is facing some heat from the SEC over charges of misleading investors about the company’s developmental lung cancer drug.
Published:
Last Updated:
After a day when shares popped 30%, Canadian marijuana grower Tilray is seeing its stock jump more than 45% again in premarket trading Wednesday.
Published:
Last Updated:
Tilray continued its incredible rally with shares up massively on Tuesday after the U.S. Drug Enforcement Administration granted approval for the company to import a cannabinoid study drug for a...
Published:
Last Updated:
Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial.
Published:
Last Updated:
CRISPR Therapeutics shares dipped on Monday after the company announced a collaboration with ViaCyte focused on the discovery, development and commercialization of gene-edited allogeneic stem cell...
Published:
Last Updated:
Clinical-stage biopharmaceutical company Urovant Sciences intends to price 10 million shares for an initial public offering valued up to $184 million.
Published:
Last Updated:
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
Published:
Last Updated:
Principia Biopharma now intends to price more than 6 million shares for an initial public offering valued up to more than $122 million.
Published:
Last Updated:
STAAR Surgical shares made a handy gain on Friday after the firm announced a key approval by the FDA.
Published:
Last Updated:
Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering.
Published:
Last Updated: